Share This

Create Your Own Business Intelligence Website   Input the stock code or the company name     Search   <03613.HK> - BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED    Stock Screener：Medicine, Chinese Medicines C.P. POKPHAND PAK FAH YEOW ALI HEALTH OCI INTL CHINAHEALTHWISE INNOVATIVE PHAR WANJIA GROUP TIANDA PHARMA SIHUAN PHARM LANSEN PHARMA GRAND PHARMA TRAD CHI MED PASHUN INT'L REGENT PACIFIC CONCH ENVIRO UNI-BIO GROUP SHANDONG XINHUA CKLIFE SCIENCES EXTRAWELL PHAR CMS BAIYUNSHAN PH WAI YUEN TONG ZHONG JIA GX C ANIMAL HEALTH LEE'S PHARM NT PHARMA ESSEX BIO-TECH CSPC PHARMA SINOPHARM KINGWORLD CMBC CAPITAL CGN MINING SINO BIOPHARM SH PIONEER HLDG OCUMENSION-B PURAPHARM LIVZON PHARMA FRONTAGE 3SBIO HEC CJ PHARM MODERN CHI MED FUSEN PHARM TONG REN TANG CONSUN PHARMA CIRC SANAI HEALTH GP SSY GROUP SIMCERE PHARMA JBM HEALTHCARE LUYE PHARMA FOSUN PHARMA UNI HEALTH CHARMACY PHAR BIOCYTOGEN-B DAWNRAYS PHARMA WUXI APPTEC HUA MEDICINE-B SH PHARMA JACOBSON PHARMA SHINEWAY PHARM LONGRUN TEA CHINARES PHARMA TYCOON GROUP HANSOH PHARMA ZHONGZHIPHARM PHARMARON UNITED LAB NEW RAY MEDIC JOINN JD HEALTH ZHAOKE OPHTH-B ASYMCHEM SINCO PHARMA GOLDEN THROAT HAO WEN HLDGS CB GLOBAL CH BIOTECH SER JILIN CHANGLONG CH DEMETER FIN GF HEALTHCARE CRMI BAYTACARE PHARM C HEALTH GP SILK RD ENERGY NEP INTERLONG LARRY JEWELRY    Basic Datum Company name Lot P/E P/B EPS DPS TONGRENTANGCM 1000 18.68 1.9658 0.65 0.33 Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend    Related links    Related news    同仁堂國藥委任代理首席執行官   《公司業績》同仁堂國藥全年純利5.4億元跌16.3% 末期息...   同仁堂國藥曾跌17% 料去年除稅後利潤下降18%至22%   《盈警響號》同仁堂科技2023年淨利潤可能最多增長7%   《盈警響號》同仁堂國藥收入下降 去年少賺18%-22%   同仁堂國藥(03613.HK)委任董事會主席  ≫More    Company Rating Date Broker Company name Rating Target 03-18  Morgan   TONGRENTANGCM  增持 15 03-18  Morgan   TONGRENTANGCM  增持 12 01-30  Morgan   TONGRENTANGCM  增持 17 ≫More    Company performance - Published Date Company name Turnover* Profit* % Dividend ≫More    Comment 2021-08-13　同仁堂國藥（3613）上半年銷售收入按年上升24.1%至7.04億元，而盈利則增長17.9%至2.67億元，同仁堂國藥股價上升逾5%，跑贏大市。   2021-08-13　同仁堂國藥來自本港的息稅前盈利按年增長12.1%至3.13億元，內地業務轉虧為盈2781萬元，而海外業務息稅前盈利則倍升至4870萬元，後兩者在去年下半年以來顯著改善。   2021-08-13　同仁堂國藥5月於天貓香港平台開設同仁堂旗艦店，配合天貓官方活動計劃及營銷日曆，策劃舉辦開站慶、品牌日、包郵日、618年中慶等一系列活動，有有望打入年輕人市場。   2021-08-13　同仁堂國藥與香港大學戰略合作，開展安宮牛黃丸及牛黃清心丸等品種的安全性和作用機理等研究，可以為未來產品進入海外主流市場提供可靠的科學依據。   2021-08-13　同仁堂國藥股價2月22日突破200天線後，過去半年一直守穩其上，若該股在是次調整期回落至該線（10.316元）附近，可以增持。      Top Gain / Loss Show All Charts     Value Name Updated Value Change Change % HSI 04-22 09:30 16513.6 ▲ 289.41 ▲ 1.78% TONGRENTANGCM 04-23 16:09 9.1 ▲ 9.1 ▲ ∞% ≫More

Mobile | Full

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map

Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved

Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.